Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer
نویسندگان
چکیده
منابع مشابه
2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer
OBJECTIVE To compare 2D and 3D radiomics features prognostic performance differences in CT images of non-small cell lung cancer (NSCLC). METHOD We enrolled 588 NSCLC patients from three independent cohorts. Two sets of 463 patients from two different institutes were used as the training cohort. The remaining cohort with 125 patients was set as the validation cohort. A total of 1014 radiomics ...
متن کاملRadiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
Radiomics characterizes tumor phenotypes by extracting large numbers of quantitative features from radiological images. Radiomic features have been shown to provide prognostic value in predicting clinical outcomes in several studies. However, several challenges including feature redundancy, unbalanced data, and small sample sizes have led to relatively low predictive accuracy. In this study, we...
متن کاملImpact of PET - CT motion correction in minimising the gross tumour volume in non-small cell lung cancer
AbstractObjective: To investigate the impact of respiratory motion on localization, and quantification lung lesions for the Gross Tumour Volume utilizing an in-house developed Auto3Dreg programme and dynamic NURBS-based cardiac-torso digitised phantom (NCAT). Methods: Respiratory motion may result in more than 30% underestimation of the SUV values of lung, liver and kidney tumour lesions. The m...
متن کاملTreatment of N2 non-small cell lung cancer (NSCLC).
1 Arriagada R, Bertino JR, Bleehen NM, Brodin 0, Feld B, Goldie JH, Hansen HH, et al and the Workshop participants. Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer. In: Arriagada R, Le Chevalier T, eds. Treatnsent modalities in lung cancer. Basel: Karger, 1988; vol 41, 232-4 1 2 S#{248}rensen JB, Hansen HH. Review of nsethodological problems in the interpret...
متن کاملPositive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
The differential diagnosis between pleural malignant mesothelioma (MM) and lung cancer is often challenging. Immunohistochemical (IHC) stains used to distinguish these malignancies include markers that are most often positive in MM and less frequently positive in carcinomas, and vice versa. However, in about 10-20% of the cases, the IHC results can be confusing and inconclusive, and novel marke...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Lung Cancer Research
سال: 2020
ISSN: 2218-6751,2226-4477
DOI: 10.21037/tlcr-20-477